Literature DB >> 25703516

The changing face of hemostasis testing in modern laboratories: consolidation, automation, and beyond.

Giuseppe Lippi1, Mario Plebani2, Emmanuel J Favaloro3.   

Abstract

The reality of laboratory diagnostics as a whole, and hemostasis testing in particular, is evolving under new paradigms of efficiency. The driving forces of health care and laboratory diagnostics in the third millennium are mainly represented by macro- and microeconomics. In a world with limited resources, shattered by an unprecedented economic crisis, laboratory diagnostics is undergoing a substantial reorganization, with emergence of new models under the imperative of terms, such as bedside testing, consolidation, and networking. The paradigms under which these changes are being developed include a variety of environment, preanalytical, technological, professional, and health-care aspects. The maintenance of continued quality is indeed the major challenge to be faced in the foreseeable future. In fact, some challenges prepotently emerge during a consolidation process, which basically involve delayed testing, centrifugation, transportation, and stability of the specimens, as well as the potential mismatch of sample matrix. This article is aimed to provide an overview of the current economic scenario of laboratory diagnostics and discuss the changing face of hemostasis testing in modern laboratories, providing a synthetic overview about potential drawbacks of actualized solutions. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Mesh:

Year:  2015        PMID: 25703516     DOI: 10.1055/s-0035-1544196

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  1 in total

1.  A comparative evaluation of the CN-6000 haemostasis analyser using coagulation, amidolytic, immuno-turbidometric and light transmission aggregometry assays.

Authors:  Chris Gardiner; Philip Lane; Katy Langley; Hitesh Tailor; Samuel J Machin; Ian J Mackie
Journal:  Int J Lab Hematol       Date:  2020-06-17       Impact factor: 3.450

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.